Aktionsplan Halozyme Therapeutics, Inc.
Über das Unternehmen
Halozyme Therapeutics, Inc. работает как компания, занимающаяся биофармацевтической технологической платформой в США, Швейцарии и на международном уровне. Продукция компании основана на технологии доставки лекарств ENHANZE, запатентованном рекомбинантном ферменте гиалуронидазы человека (rHuPH20), который обеспечивает подкожную доставку инъекционных биопрепаратов, таких как моноклональные антитела и другие терапевтические молекулы, а также небольших молекул и жидкостей.
Weitere DetailsP/E | 46.24 |
---|---|
P/S | 13.06 |
P/BV | 27.89 |
EV/EBITDA | -44.72 |
EBITDA | -0.0635 |
Цена ао | 49.3 |
Сайт | http://www.halozyme.com |
Число акций ао | 0.1342 млрд |
Выручка | 0.196 |
Див.доход ао | 0 |
ISIN | US40637H1095 |
Валюта | usd |
IPO date | 2004-03-16 |
Sector | Health Care |
Industry | Biotechnology |
Валюта отчета | usd |
Preisänderung pro Tag: | -6.98% (53) |
---|---|
Preisänderung pro Woche: | -8.45% (53.85) |
Preisänderung pro Monat: | -18.57% (60.54) |
Preisänderung über 3 Monate: | -10.53% (55.1) |
Preisänderung über sechs Monate: | +28.45% (38.38) |
Preisänderung pro Jahr: | +33.21% (37.01) |
Preisänderung über 3 Jahre: | +51.27% (32.59) |
Preisänderung über 5 Jahre: | +156.1% (19.25) |
Preisänderung seit Jahresbeginn: | +43.73% (34.3) |
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
Transaktionsdatum | Offenlegungsdatum | Insider | Typ | Preis | Volumen | Menge | Teilen bis zu, % | Danach teilen, % | Dokumentieren |
---|---|---|---|---|---|---|---|---|---|
09.10.2024 | 09.10.2024 | HELEN TORLEY Officer |
Kaufen | 52.58 | 525 800 | 10000 | 0 | 0.01 | Link |
08.10.2024 | 08.10.2024 | HELEN TORLEY Officer |
Kaufen | 54 | 540 000 | 10000 | 0 | 0.01 | Link |
26.09.2024 | 26.09.2024 | HELEN TORLEY Officer |
Kaufen | 56.1 | 561 000 | 10000 | 0 | 0.01 | Link |
25.09.2024 | 25.09.2024 | HELEN TORLEY Officer |
Kaufen | 56.34 | 563 400 | 10000 | 0 | 0.01 | Link |
24.09.2024 | 24.09.2024 | HELEN TORLEY Officer |
Kaufen | 58.21 | 582 100 | 10000 | 0 | 0.01 | Link |
11.09.2024 | 11.09.2024 | HELEN TORLEY Officer |
Kaufen | 59.09 | 590 900 | 10000 | 0 | 0.01 | Link |
10.09.2024 | 10.09.2024 | HELEN TORLEY Officer |
Kaufen | 59.09 | 590 900 | 10000 | 0 | 0.01 | Link |
27.08.2024 | 27.08.2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Kaufen | 18.41 | 102 728 | 5580 | 0 | 0 | Link |
20.08.2024 | 20.08.2024 | MICHAEL LABARRE Officer |
Kaufen | 61.06 | 610 600 | 10000 | 0 | 0.01 | Link |
28.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Verkauf | 52.04 | 520 400 | 10000 | 0 | -0.01 | Link |
28.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Kaufen | 22.5 | 225 000 | 10000 | 0 | 0.01 | Link |
27.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Verkauf | 51.93 | 519 300 | 10000 | 0 | -0.01 | Link |
27.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Kaufen | 22.5 | 225 000 | 10000 | 0 | 0.01 | Link |
26.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Verkauf | 51.82 | 518 200 | 10000 | 0 | -0.01 | Link |
26.06.2024 | 28.06.2024 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
Kaufen | 22.5 | 225 000 | 10000 | 0 | 0.01 | Link |
17.04.2024 | 17.04.2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Verkauf | 38.49 | 384 900 | 10000 | 0 | -0.01 | Link |
17.04.2024 | 17.04.2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Kaufen | 8.11 | 81 100 | 10000 | 0 | 0.01 | Link |
16.04.2024 | 17.04.2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Verkauf | 38.35 | 383 500 | 10000 | 0 | -0.01 | Link |
16.04.2024 | 17.04.2024 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Kaufen | 8.11 | 81 100 | 10000 | 0 | 0.01 | Link |
03.01.2023 | 04.01.2023 | Snyder Mark Howard SVP, GENERAL COUNSEL |
Kaufen | 53.98 | 410 842 | 7611 | 0 | 0.01 | Link |
13.12.2022 | 13.12.2022 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
Verkauf | 58.67 | 586 700 | 10000 | 0 | -0.01 | Link |
15.02.2022 | 17.02.2022 | Torley Helen President and CEO |
Kaufen | 33.1 | 433 345 | 13092 | 0 | 0.01 | Link |
15.02.2022 | 17.02.2022 | LaBrosse Nicole SVP, Chief Financial Officer |
Kaufen | 33.1 | 41 541 | 1255 | 0 | 0 | Link |
15.02.2022 | 17.02.2022 | LaBarre Michael J. SVP, Chief Technical Officer |
Kaufen | 33.1 | 112 077 | 3386 | 0 | 0 | Link |
12.10.2021 | 12.10.2021 | LaBarre Michael J. SVP, Chief Technical Officer |
Kaufen | 13.1 | 105 455 | 8050 | 0 | 0.01 | Link |
04.10.2021 | 04.10.2021 | Torley Helen President and CEO |
Verkauf | 40.09 | 2 004 500 | 50000 | 0 | -0.04 | Link |
04.10.2021 | 04.10.2021 | Torley Helen President and CEO |
Kaufen | 14.66 | 733 000 | 50000 | 0 | 0.04 | Link |
01.10.2021 | 01.10.2021 | LaBarre Michael J. SVP, Chief Technical Officer |
Verkauf | 39.93 | 1 175 940 | 29450 | 0 | -0.02 | Link |
01.10.2021 | 01.10.2021 | LaBarre Michael J. SVP, Chief Technical Officer |
Kaufen | 13.1 | 385 795 | 29450 | 0 | 0.02 | Link |
10.08.2021 | 10.08.2021 | Torley Helen President and CEO |
Verkauf | 41.11 | 2 055 500 | 50000 | 0 | -0.04 | Link |
10.08.2021 | 10.08.2021 | Torley Helen President and CEO |
Kaufen | 14.66 | 733 000 | 50000 | 0 | 0.04 | Link |
15.07.2021 | 15.07.2021 | LaBarre Michael J. SVP, Chief Technical Officer |
Kaufen | 6.55 | 96 187 | 14685 | 0 | 0.01 | Link |
01.02.2021 | 01.02.2021 | Torley Helen President and CEO |
Verkauf | 47.84 | 2 392 000 | 50000 | 0 | -0.03 | Link |
01.02.2021 | 01.02.2021 | Torley Helen President and CEO |
Kaufen | 14.66 | 733 000 | 50000 | 0 | 0.03 | Link |
01.02.2021 | 01.02.2021 | Kelley Kenneth J Director |
Verkauf | 48.12 | 240 600 | 5000 | 0 | 0 | Link |
21.12.2020 | 21.12.2020 | LaBarre Michael J. SVP, Chief Technical Officer |
Verkauf | 42.58 | 510 960 | 12000 | 0 | -0.01 | Link |
Institutionen | Volumen | Aktie, % |
---|---|---|
Blackrock Inc. | 18630963 | 14.66 |
Vanguard Group Inc | 13259514 | 10.44 |
Artisan Partners Limited Partnership | 6689058 | 5.26 |
State Street Corporation | 6475549 | 5.1 |
Snyder Capital Management, LP | 3709599 | 2.92 |
AllianceBernstein L.P. | 3463694 | 2.73 |
Macquarie Group Limited | 3282640 | 2.58 |
JP Morgan Chase & Company | 3093932 | 2.44 |
Geode Capital Management, LLC | 2919763 | 2.3 |
GW&K Investment Management, LLC | 2226538 | 1.75 |
Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
---|---|---|---|
Ms. Amy Marinne Fox | Chief Human Resources Officer | N/A | |
Dr. Helen I. Torley M.B. Ch. B., M.R.C.P. | President, CEO & Director | 1.82M | 1963 (61 Jahr) |
Ms. Nicole LaBrosse | Senior VP & CFO | 849.36k | 1983 (41 Jahr) |
Mr. Mark Snyder Esq. | Senior VP & Chief Legal Officer | 912.87k | |
Ms. Tram Bui | Head of Investor Relations & Corporate Communications | N/A | |
Dr. Michael J. LaBarre Ph.D. | Senior VP & CTO | 843.89k | 1964 (60 Jahre) |
Ms. Cortney Caudill M.B.A. | Chief Operations Officer | N/A | |
Mr. Gary Grote | Chief Commercial Officer | ||
Dr. Christopher Wahl M.B.A., M.D. | Chief Business Officer |
Webseite: http://www.halozyme.com